Journal
MOLECULES
Volume 19, Issue 11, Pages 18073-18089Publisher
MDPI AG
DOI: 10.3390/molecules191118073
Keywords
methylpenicinoline; Penicillium sp.; marine fungus; anti-inflammation; nuclear factor-kappa B (NF-kappa B); mitogen-activated protein kinase (MAPK)
Funding
- Ministry of Oceans and Fisheries' RD project [PM13030]
Ask authors/readers for more resources
In the course of a search for anti-inflammatory metabolites from marine-derived fungi, methylpenicinoline (1) was isolated from a marine isolate of Penicillin sp. Compound 1 inhibited lipopolysaccharide (LPS)-stimulated nitric oxide (NO) production by suppressing the expression of inducible NO synthase (iNOS) in RAW264.7 macrophages and BV2 microglia. It also attenuated prostaglandin E-2 (PGE(2)) production by suppressing cyclooxygenase-2 (COX-2) expression in a concentration-dependent manner (from 10 mu M to 80 mu M) without affecting cell viability. In addition, compound 1 reduced the production of the pro-inflammatory cytokine interleukin-1 beta (IL-1 beta). In a further study designed to elucidate the mechanism of its anti-inflammatory effects, compound 1 was shown to block nuclear factor-kappa B (NF-kappa B) activation in LPS-induced RAW264.7 macrophages and BV2 microglia by inhibiting the phosphorylation of inhibitor kappa B-alpha (I kappa B-alpha), thereby suppressing the nuclear translocation of NF-kappa B dimers, namely p50 and p65, that are known to be crucial molecules associated with iNOS and COX-2 expression. In addition, compound 1 inhibited the activation of mitogen-activated protein kinase (MAPK) pathways. Taken together, the results suggest that compound 1 might be a valuable therapeutic agent for the treatment of anti-inflammatory and anti-neuroinflammatory diseases.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available